This page covers gynecological oncology thesis topics across cervical cancer and premalignant cervical lesions, endometrial cancer, ovarian and fallopian tube malignancies, vulvar, vaginal and gestational trophoblastic neoplasia, and gynecological cancer surgery, imaging, pathology and perioperative outcomes for MD Obstetrics and Gynaecology candidates. The emphasis is on gynecological oncology research topics that can be completed within one thesis period using patients already undergoing screening, imaging, biopsy, surgery, chemotherapy or radiotherapy together with routinely generated pathology and perioperative records. A shortlisted question should then be converted into a disease-specific obstetrics and gynaecology oncology protocol and a submission-ready obstetrics and gynaecology oncology synopsis.
Last reviewed and updated: September 2026 · 2026–27 admissions
Cervical Cancer and Premalignant Cervical Lesions
- Clinical and demographic profile of women with carcinoma cervix and its association with stage at diagnosis: a cross-sectional observational study.
- Association of age, parity, and socioeconomic characteristics with stage of carcinoma cervix at presentation: a cross-sectional analytical study.
- Pattern of presenting symptoms and their association with clinical stage in women with carcinoma cervix: a cross-sectional analytical study.
- Association of duration of symptoms with advanced-stage presentation in carcinoma cervix: a cross-sectional analytical study.
- Prevalence and clinicopathological characteristics of cervical intraepithelial neoplasia among women undergoing colposcopy for abnormal cervical screening tests: a cross-sectional observational study.
- Diagnostic accuracy of visual inspection with acetic acid for detecting high-grade cervical intraepithelial neoplasia using histopathology as the reference standard.
- Diagnostic accuracy of cervical cytology for detecting high-grade cervical intraepithelial neoplasia among women undergoing colposcopy.
- Correlation of cervical cytology findings with colposcopic impression and histopathology in women with abnormal cervical screening tests.
- Diagnostic accuracy of colposcopy for detecting high-grade cervical intraepithelial neoplasia using directed biopsy histopathology as the reference standard.
- Concordance between colposcopic impression and histopathological grade of cervical intraepithelial neoplasia: a diagnostic agreement study.
- Association of transformation zone type with detection of high-grade cervical intraepithelial neoplasia at colposcopy: a cross-sectional analytical study.
- Clinical and colposcopic predictors of high-grade cervical intraepithelial neoplasia among women with abnormal cervical cytology: a cross-sectional analytical study.
- Comparison of clinicopathological characteristics of squamous cell carcinoma and adenocarcinoma of the cervix: a comparative cross-sectional study.
- Association of tumour size with parametrial involvement in carcinoma cervix: a cross-sectional analytical study.
- Association of clinical stage with hydronephrosis and other local complications in carcinoma cervix: a cross-sectional analytical study.
- Correlation of clinical pelvic examination findings with magnetic resonance imaging findings in staging of carcinoma cervix: a prospective observational study.
- Diagnostic accuracy of magnetic resonance imaging for detecting parametrial invasion in carcinoma cervix using operative or histopathological findings where applicable as reference standards.
- Association of pre-treatment haemoglobin concentration with clinical stage and tumour characteristics in carcinoma cervix: a cross-sectional analytical study.
- Association of serum squamous cell carcinoma antigen, when routinely available, with clinical stage and tumour burden in squamous carcinoma cervix: a cross-sectional analytical study.
- Predictors of advanced-stage carcinoma cervix at first presentation in women attending a tertiary care hospital: a cross-sectional analytical study.
Endometrial Cancer
- Clinical and demographic profile of women with endometrial carcinoma and its association with histopathological characteristics: a cross-sectional observational study.
- Association of body mass index with tumour grade and stage in women with endometrial carcinoma: a cross-sectional analytical study.
- Association of diabetes mellitus and hypertension with adverse clinicopathological features in endometrial carcinoma: a cross-sectional analytical study.
- Comparison of clinicopathological characteristics of premenopausal and postmenopausal women with endometrial carcinoma: a comparative cross-sectional study.
- Association of duration of postmenopausal bleeding with stage of endometrial carcinoma at diagnosis: a cross-sectional analytical study.
- Diagnostic accuracy of transvaginal ultrasonography for assessment of deep myometrial invasion in endometrial carcinoma using histopathology as the reference standard.
- Diagnostic accuracy of magnetic resonance imaging for detection of deep myometrial invasion in endometrial carcinoma.
- Comparative diagnostic accuracy of transvaginal ultrasonography and magnetic resonance imaging for detecting deep myometrial invasion in endometrial carcinoma.
- Diagnostic accuracy of magnetic resonance imaging for identifying cervical stromal invasion in endometrial carcinoma.
- Correlation of preoperative magnetic resonance imaging stage with final surgical-pathological stage in endometrial carcinoma.
- Concordance between preoperative endometrial biopsy grade and final hysterectomy histopathological grade in endometrioid endometrial carcinoma.
- Concordance between preoperative biopsy histological subtype and final hysterectomy histopathology in endometrial carcinoma.
- Predictors of histological upgrading following hysterectomy in women with preoperative low-grade endometrioid carcinoma: a cross-sectional analytical study.
- Association of tumour size with deep myometrial invasion in endometrial carcinoma: a cross-sectional analytical study.
- Association of lymphovascular space invasion with pelvic lymph node metastasis in endometrial carcinoma: a cross-sectional analytical study.
- Predictors of pelvic lymph node metastasis using routinely available clinicopathological parameters in endometrial carcinoma: a cross-sectional analytical study.
- Diagnostic performance of preoperative serum cancer antigen 125 for predicting extrauterine disease in endometrial carcinoma.
- Comparison of perioperative outcomes of laparoscopic and open surgery for apparent early-stage endometrial carcinoma: a comparative observational study.
- Association of obesity with operative and immediate postoperative outcomes in women undergoing surgery for endometrial carcinoma: a prospective observational study.
- Predictors of postoperative adjuvant treatment requirement using preoperative clinical, imaging, and biopsy parameters in endometrial carcinoma: a cross-sectional analytical study.
Ovarian and Fallopian Tube Malignancies
- Clinical and demographic profile of women with epithelial ovarian cancer and its association with stage at diagnosis: a cross-sectional observational study.
- Pattern of presenting symptoms and their association with advanced-stage epithelial ovarian cancer: a cross-sectional analytical study.
- Association of menopausal status with histological subtype and stage of epithelial ovarian cancer: a cross-sectional analytical study.
- Correlation of preoperative serum cancer antigen 125 levels with stage and tumour burden in epithelial ovarian cancer: a cross-sectional analytical study.
- Association of serum cancer antigen 125 level with ascites, peritoneal deposits, and omental involvement in epithelial ovarian cancer: a cross-sectional analytical study.
- Diagnostic accuracy of the Risk of Malignancy Index for differentiating benign and malignant adnexal masses using histopathology as the reference standard.
- Comparative diagnostic accuracy of Risk of Malignancy Index and International Ovarian Tumour Analysis ultrasound-based assessment for prediction of malignancy in adnexal masses.
- Diagnostic accuracy of International Ovarian Tumour Analysis Simple Rules for differentiating benign and malignant adnexal masses using histopathology as the reference standard.
- Correlation of ultrasonographic morphology of adnexal masses with final histopathological diagnosis: a prospective observational study.
- Diagnostic accuracy of ultrasound-based subjective assessment for prediction of ovarian malignancy in women undergoing surgery for adnexal masses.
- Association of ascites volume with stage and cytoreductive surgical findings in epithelial ovarian cancer: a cross-sectional analytical study.
- Association of preoperative serum cancer antigen 125 with optimal cytoreduction in epithelial ovarian cancer: a prospective observational study.
- Predictors of optimal primary cytoreductive surgery using clinical, biochemical, and imaging parameters in epithelial ovarian cancer: a prospective observational study.
- Correlation of preoperative computed tomography findings with intraoperative disease distribution in epithelial ovarian cancer: a prospective observational study.
- Association of peritoneal carcinomatosis distribution with feasibility of optimal cytoreduction in epithelial ovarian cancer: a cross-sectional analytical study.
- Comparison of clinicopathological characteristics of serous and non-serous epithelial ovarian cancers: a comparative cross-sectional study.
- Clinicopathological characteristics of ovarian malignancy in premenopausal versus postmenopausal women: a comparative cross-sectional study.
- Association of preoperative anaemia and serum albumin with perioperative morbidity following cytoreductive surgery for ovarian cancer: a prospective observational study.
- Predictors of perioperative blood transfusion during cytoreductive surgery for epithelial ovarian cancer: a prospective observational study.
- Factors associated with prolonged postoperative hospital stay following surgery for ovarian malignancy: a prospective observational study.
Vulvar, Vaginal, and Gestational Trophoblastic Neoplasia
- Clinical and demographic profile of women with vulvar carcinoma and its association with stage at diagnosis: a cross-sectional observational study.
- Pattern of presenting symptoms and delay in presentation among women with vulvar carcinoma: a cross-sectional observational study.
- Association of primary vulvar tumour size with inguinofemoral lymph node involvement: a cross-sectional analytical study.
- Association of tumour location and depth of invasion with lymph node metastasis in vulvar carcinoma: a cross-sectional analytical study.
- Correlation of clinical inguinal lymph node assessment with histopathological nodal status in vulvar carcinoma.
- Diagnostic accuracy of ultrasonographic evaluation of inguinal lymph nodes in women with vulvar carcinoma using histopathology as the reference standard.
- Clinicopathological characteristics and operative outcomes of women undergoing surgery for vulvar carcinoma: a retrospective observational study.
- Predictors of postoperative wound complications following surgery for vulvar carcinoma: a prospective observational study.
- Association of extent of vulvar surgery with immediate postoperative morbidity and hospital stay: a comparative observational study.
- Clinical and pathological profile of primary vaginal malignancies managed at a tertiary care centre: a retrospective observational study.
- Clinical profile and risk stratification of women with gestational trophoblastic neoplasia: a cross-sectional observational study.
- Association of pretreatment serum beta-human chorionic gonadotropin concentration with International Federation of Gynecology and Obstetrics risk score in gestational trophoblastic neoplasia: a cross-sectional analytical study.
- Clinical predictors of high-risk gestational trophoblastic neoplasia among women following molar pregnancy: a cross-sectional analytical study.
- Comparison of clinical characteristics of low-risk and high-risk gestational trophoblastic neoplasia: a comparative cross-sectional study.
- Association of uterine size with serum beta-human chorionic gonadotropin levels and risk category in gestational trophoblastic neoplasia: a cross-sectional analytical study.
- Ultrasonographic characteristics of gestational trophoblastic neoplasia and their association with pretreatment serum beta-human chorionic gonadotropin levels: a cross-sectional analytical study.
- Association of theca lutein cysts with biochemical severity and risk classification in gestational trophoblastic disease: a cross-sectional analytical study.
- Clinical and laboratory predictors of persistent gestational trophoblastic neoplasia following evacuation of hydatidiform mole: a retrospective case-control study.
- Association of pretreatment anaemia with disease burden in gestational trophoblastic neoplasia: a cross-sectional analytical study.
- Immediate treatment response and treatment-related adverse effects among women receiving first-line therapy for low-risk gestational trophoblastic neoplasia: a prospective observational study.
Gynecological Cancer Surgery, Imaging, Pathology, and Perioperative Outcomes
- Pattern of gynecological malignancies managed surgically at a tertiary care teaching hospital: a retrospective observational study.
- Clinical and pathological distribution of cervical, endometrial, ovarian, vulvar, and other gynecological malignancies presenting to a tertiary care centre: a cross-sectional observational study.
- Association of preoperative anaemia with perioperative blood transfusion in women undergoing surgery for gynecological malignancies: a prospective observational study.
- Association of preoperative serum albumin with postoperative morbidity in women undergoing major gynecological cancer surgery: a prospective observational study.
- Association of body mass index with perioperative outcomes following surgery for gynecological malignancies: a prospective observational study.
- Predictors of prolonged operative time during major gynecological oncology surgery: a prospective observational study.
- Predictors of significant intraoperative blood loss during gynecological cancer surgery: a prospective observational study.
- Factors associated with perioperative blood transfusion among women undergoing surgery for gynecological malignancies: a prospective observational study.
- Pattern and predictors of intraoperative complications during surgery for gynecological malignancies: a prospective observational study.
- Frequency and predictors of postoperative complications during the index admission following major gynecological oncology surgery: a prospective observational study.
- Predictors of prolonged postoperative hospital stay after surgery for gynecological malignancies: a prospective observational study.
- Factors associated with postoperative intensive care requirement following major gynecological cancer surgery: a retrospective observational study.
- Association of preoperative functional status with immediate postoperative outcomes in women undergoing gynecological cancer surgery: a prospective observational study.
- Comparison of perioperative outcomes of minimally invasive and open surgery for appropriately selected early-stage gynecological malignancies: a comparative observational study.
- Concordance between preoperative imaging stage and final surgical-pathological stage across common gynecological malignancies: a prospective observational study.
- Diagnostic accuracy of preoperative imaging for detecting pelvic lymph node metastasis in gynecological malignancies using histopathology as the reference standard.
- Association of preoperative neutrophil-to-lymphocyte ratio with stage and pathological risk features in common gynecological malignancies: a cross-sectional analytical study.
- Association of platelet-to-lymphocyte ratio with clinicopathological characteristics of gynecological malignancies: a cross-sectional analytical study.
- Predictors of postoperative complications using routinely available preoperative clinical and laboratory parameters in women undergoing gynecological oncology surgery: a prospective observational study.
- Comparison of clinical, operative, and immediate postoperative outcomes among women undergoing surgery for cervical, endometrial, and ovarian malignancies: a comparative observational study.
Not the obstetrics and gynaecology subspeciality you need? Gynecological oncology in obstetrics and gynecology is one section of our full obstetrics and gynaecology collection — the hub page lists every subspeciality, each with its own free topic list. Updated September 2026.
All Obstetrics and Gynaecology Topics →
📌 Updated for 2026–2027 MD Obstetrics and Gynaecology Gynecological Oncology admissions
The research framework was reviewed across cervical, endometrial, ovarian, vulvar, vaginal and gestational trophoblastic neoplasia with particular attention to screening, staging, pathology, surgical selection and immediate treatment outcomes.
- Most projects can be completed with routinely available screening tests, tumour markers where clinically obtained, ultrasonography, magnetic resonance imaging or computed tomography, biopsy histopathology, operative findings and oncology treatment records.
- Research-only biopsies, molecular panels, additional imaging, lymph-node dissection, tumour-marker testing or invasive procedures are not required unless they are already clinically indicated and specifically approved.
- Publication potential is strongest when each malignancy is analysed with its own stage, reference standard and outcome pathway rather than pooling biologically different cancers into one undifferentiated oncology cohort.
Generate a protocol from any topic above
Select Generate Protocol → beside any title in the list above and receive a submission-ready document built around that topic, containing all eighteen components:
- Introduction / Synopsis
- Research Question
- Aim of the Study
- Primary Objective
- Secondary Objectives
- Materials and Methods
- Inclusion Criteria
- Exclusion Criteria
- Sample Size Calculation
- Methodology
- Statistical Analysis
- Ethical Considerations
- Review of Literature
- References
- Gantt Chart / Study Timeline
- Patient Information Sheet
- Consent Form
- Data Collection Form
Already have your thesis title?
Generate the full gynecological oncology in obstetrics and gynecology protocol directly — objectives, methodology, sample size, statistics, timeline, references and annexures.
Generate your protocol
Alongside gynecological oncology in obstetrics and gynecology protocols and synopses, support is also available for departmental presentations, journal club presentations, ethics committee presentations, and posters and oral presentations for medical conferences — for postgraduate residents, board trainees and research scholars across India and the GCC. Prepared by a practising doctor with long experience in medical publishing and thesis supervision.
Enquire on WhatsApp →
Gynecological oncology in obstetrics and gynecology research outside India
The topics above work as research questions anywhere — what changes is the document the institution expects, and who approves it before data collection begins. The Gulf equivalent of an Indian synopsis is the gynecological oncology in obstetrics and gynecology research proposal submitted to an institutional review board, and it ordinarily carries three sections an Indian synopsis does not: a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.
Board and residency programmes — country by country
Saudi Arabia — SCFHS and the Saudi Board. Residency and fellowship training under the Saudi Commission for Health Specialties includes a research project with a set timeline, and the gynecological oncology in obstetrics and gynecology research proposal is the document prepared at the outset and cleared by the institutional review board before recruitment starts.
United Arab Emirates — DHA, DOH Abu Dhabi and MOHAP. Residents training in Dubai, Abu Dhabi and the northern emirates prepare a gynecological oncology in obstetrics and gynecology research protocol for their programme and submit it for institutional review board approval before any data are collected.
Qatar — DHP (formerly QCHP) and Hamad Medical Corporation. A gynecological oncology in obstetrics and gynecology IRB proposal is reviewed before recruitment, with the ethics section written to the institution's own template rather than a generic one.
Bahrain — NHRA. Trainees turning gynecological oncology in obstetrics and gynecology research topics into a project need the proposal cleared by their institutional research and ethics committee before fieldwork begins.
Oman — OMSB. Residency programmes under the Oman Medical Specialty Board include a research component, and the gynecological oncology in obstetrics and gynecology research proposal is the document assessed at the start of it.
Kuwait — KIMS. A gynecological oncology in obstetrics and gynecology study protocol goes to the institutional committee for approval before the project begins.
Arab Board programmes across the region. The Arab Board carries its own research requirement irrespective of the host country, and the gynecological oncology in obstetrics and gynecology proposal follows the same structure throughout.
Postgraduate degrees — Malaysia, the Gulf and beyond
Malaysia — MMed, the National Medical Research Register and MREC. A gynecological oncology in obstetrics and gynecology dissertation proposal for a Master of Medicine programme carried out in a Ministry of Health facility must be registered on the NMRR and approved by the Medical Research and Ethics Committee before the study begins, and the guidance asks for submission four to six months ahead of data collection. Every investigator on the study team registers on the NMRR as well, so the methodology, ethics and team sections are written in far more detail than an Indian synopsis requires.
PhD and Master's candidates elsewhere. University programmes generally require a full gynecological oncology in obstetrics and gynecology research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter.
PhD and MMed proposals are written individually by a medical doctor and revised until the supervisor accepts them. They are not produced by the automated protocol generator.
Enquire about a gynecological oncology in obstetrics and gynecology PhD or MMed proposal →
🔥 Trending research areas in Gynecological Oncology for 2026–27
Current gynecological-oncology research increasingly integrates molecular risk, targeted screening and less morbid surgical staging with conventional clinicopathological assessment.
- Human papillomavirus-based cervical screening and self-sampling: primary human papillomavirus testing, extended genotyping and self-collected samples are creating practical research questions around screening uptake, triage and linkage to colposcopy.
- Molecularly integrated endometrial-cancer classification: POLE-mutated, mismatch-repair-deficient, p53-abnormal and no-specific-molecular-profile groups are increasingly incorporated with stage and histopathology when defining prognosis and adjuvant-treatment risk.
- BRCA and homologous-recombination testing in tubo-ovarian cancer: genomic testing is increasingly relevant at diagnosis because it influences hereditary-cancer assessment and eligibility for maintenance strategies in high-grade non-mucinous tubo-ovarian carcinoma.
- Sentinel lymph-node staging: sentinel-node mapping and ultrastaging are increasingly used to reduce the morbidity of full lymphadenectomy in appropriately selected endometrial, cervical and vulvar cancers, creating practical studies of mapping success and nodal detection.
Protocol and synopsis guidance
What a Gynecological Oncology protocol must contain
A gynecological oncology protocol must first define the primary tumour type, because cervical, endometrial, ovarian, vulvar, vaginal and gestational trophoblastic neoplasia have different staging systems, biomarkers, treatment pathways and reference standards. The protocol should state the index population, pretreatment stage, imaging method, pathological endpoint, operative or treatment exposure and the exact maternal or oncological outcome being analysed.
The denominator must remain disease-specific. A woman undergoing radical hysterectomy for cervical cancer, staging hysterectomy for endometrial cancer and cytoreductive surgery for ovarian cancer undergoes operations of very different complexity. Pooling these patients to study blood loss, complications or length of stay without accounting for tumour site, stage and procedure type can create associations that merely reflect the operation performed rather than the predictor being studied.
Reference-standard availability must be planned before analysis. Surgical histopathology is available only in women selected for surgery, while advanced or medically inoperable patients may have imaging, biopsy and treatment records without complete surgical staging. Diagnostic-performance claims should therefore be restricted to the population in which the reference standard is actually applicable rather than assuming missing pathology represents a negative finding.
Gynecological Oncology synopsis versus Gynecological Oncology protocol
A gynecological oncology synopsis can state the tumour type, research question, broad design and principal endpoint. The full protocol must convert those statements into reproducible definitions for pretreatment stage, biopsy histology, imaging criteria, tumour markers, nodal assessment, operative findings, pathological risk factors, treatment exposure and the exact timing of postoperative or treatment-response outcomes.
For diagnostic studies, the protocol should distinguish agreement between clinical examination, imaging and pathology from true diagnostic accuracy against an independent reference. For surgical studies, the procedure type and extent should be prespecified. For multi-cancer service studies, the analysis should either remain descriptive or stratify appropriately by primary site and procedure instead of implying that all gynecological malignancies have one common biological risk model.
Sample size and statistical analysis
Sample size should follow the primary endpoint and tumour type. A prevalence study of cervical precancer needs an expected proportion and desired precision; a diagnostic study of an adnexal-mass model requires enough benign and malignant final diagnoses; and a perioperative study needs enough procedures with the prespecified complication to support the intended analysis. Rare vulvar, vaginal or trophoblastic outcomes may require retrospective data or multicentre recruitment when local volume is low.
Several statistical units can exist in one oncology study. The patient is usually the primary unit, but lymph nodes, lesions, operative procedures or repeated chemotherapy cycles may generate multiple observations from one patient. These should not automatically be treated as independent cases. Sentinel-node studies, for example, should distinguish patient-level mapping success from hemi-pelvis-level or node-level detection.
Prediction models should include only variables available before the outcome being predicted and should avoid overfitting small datasets with many candidate biomarkers. Agreement statistics are preferable when comparing two staging assessments, while sensitivity and specificity require an independent reference standard. Internally derived cut-offs for tumour markers or inflammatory indices should be described as local until externally validated.
Frequently Asked Questions – Gynecological Oncology Thesis Topics In Obstetrics And Gynecology (2026–27)
1. How do I choose a feasible Gynecological Oncology thesis topic for 2026 admission?
Start with the malignancies and procedures that occur frequently enough in the unit to provide a complete dataset within the thesis period. Cervical, endometrial or ovarian cancer usually offers greater single-centre volume than rare vulvar, vaginal or trophoblastic malignancy. Confirm that the required screening, imaging, pathology, operative or treatment reference data are consistently available before choosing a diagnostic, staging or perioperative question.
2. Which study designs are accepted for Gynecological Oncology research?
Suitable designs include descriptive and analytical cross-sectional studies, comparative studies, case-control studies, diagnostic-accuracy studies, agreement studies, prospective or retrospective cohorts and perioperative observational studies. The design should follow the timing of exposure and outcome. Stage-at-presentation studies can be cross-sectional, while postoperative morbidity, treatment interruption or immediate chemotherapy response requires longitudinal observation.
3. What should I settle with my guide before registering a Gynecological Oncology topic?
Settle the primary tumour type, stage system, inclusion criteria, index test or exposure, reference standard, surgical or treatment pathway, primary endpoint and whether the dataset contains one cancer type or several. If several malignancies are included, decide beforehand whether results will be reported descriptively, stratified by tumour type or adjusted for procedure and stage.
4. Can I combine different gynecological cancers into one thesis cohort?
Yes for service-profile questions such as the distribution of cancers treated in a unit, but caution is required for analytical studies. Cervical, endometrial, ovarian, vulvar and trophoblastic malignancies differ in stage, surgery, tumour markers and treatment. A pooled analysis of complications, nodal disease or treatment response may be misleading unless tumour site, stage and procedure type are explicitly handled. A single-cancer cohort is usually methodologically cleaner for postgraduate analytical work.
5. What is the difference between a Gynecological Oncology synopsis and protocol?
The synopsis is the concise institutional submission describing the tumour type, research question, objectives, design and broad methods. The protocol is the operational document that fixes stage definitions, imaging or screening criteria, pathology endpoints, operative variables, treatment exposure, reference standard, outcome timing, missing-data rules and the statistical analysis corresponding to every objective.
6. What ethics issues are important in Gynecological Oncology research?
Research should separate clinically indicated screening, biopsy, imaging, surgery, tumour-marker testing and molecular testing from procedures added solely for the study. Additional biopsy, lymph-node sampling, imaging, contrast, radiation exposure or research-only venepuncture should not be added merely to complete a thesis without specific justification and informed consent. If additional blood sampling is genuinely required, the purpose and permitted blood volume should be stated. Retrospective pathology, operative-record or PACS studies may qualify for an ethics-approved waiver of individual consent.
Prospective participants should provide informed consent, with guardian consent and age-appropriate assent where a minor is eligible under applicable law and institutional policy. Histopathology images, colposcopic photographs, radiology images and operative recordings should be anonymised before research export, and separate consent is required for identifiable photographs or video. The protocol should define the escalation pathway for newly detected invasive malignancy, suspicious nodal or metastatic disease, hereditary-cancer findings, severe treatment toxicity or another result requiring prompt oncology referral or treatment modification.
7. What is the biggest methodological error in a Gynecological Oncology thesis?
The sharpest error is treating all gynecological malignancies as though they belong to one biological and surgical population. A predictor associated with postoperative morbidity in a pooled dataset may simply identify women undergoing larger ovarian cytoreductive procedures rather than a true independent patient risk factor. The same problem occurs when one common stage or nodal endpoint is imposed across cancers with different staging systems.
A closely related error is using surgical histopathology as the reference standard while silently excluding advanced or inoperable women who never undergo surgery. The protocol should therefore define one tumour-specific analysis level and one applicable reference pathway before recruitment or data extraction begins.
8. How does a Gynecological Oncology MD thesis differ from PhD and Gulf board research pathways?
An MD synopsis is usually a focused residency dissertation based on a defined screening, staging, pathology, surgery or treatment question that can be completed within one training period. A PhD proposal requires a broader original programme, a clearer knowledge gap and usually greater molecular, translational, multicentre or longitudinal depth.
Residents beyond the Indian MD pathway should align the project with the mandatory board research project required within SCFHS and Saudi Board training, Arab Board of Health Specializations requirements, and institutional or programme processes linked to DHP, DHA, DOH and MOHAP. Proposal format, supervision, ethics approval, molecular-testing governance and completion milestones should follow the relevant training authority.
9. When should I register my Gynecological Oncology thesis topic?
Register after confirming tumour-specific case volume, stage system, index assessment, reference standard, treatment pathway and availability of pathology or operative data, but before prospective recruitment or research-specific data collection begins. For retrospective work, fix the study period, tumour definitions and analysis plan before reviewing outcomes so that case selection is not influenced by final stage, pathology or treatment result.
Found a topic that fits your department?
Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.
Generate your protocol
